Metis Global Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $329K | Sell |
|
|||||
|
2025
Q2 | $308K | Sell |
|
|||||
|
2025
Q1 | $342K | Buy |
|
|||||
|
2024
Q4 | $348K | Buy |
|
|||||
|
2024
Q3 | $282K | Buy |
|
|||||
|
2024
Q2 | $309K | Buy |
|
|||||
|
2024
Q1 | $305K | Sell |
|
|||||
|
2023
Q4 | $294K | Sell |
|
|||||
|
2023
Q3 | $266K | Buy |
|
|||||
|
2023
Q2 | $213K | Buy |
|
|||||
|
2023
Q1 | $210K | Buy |
|